Extremely elevated serum alkaline phosphatase level upon treatment with teriparatide: a case report
Abstract Background Teriparatide is a homolog of human parathyroid hormone (1–34), which is approved for the treatment of postmenopausal and glucocorticoid-induced osteoporosis. Several minor and transient side effects have been reported for teriparatide. However, controversial findings showed an in...
Main Authors: | Ali Javinani, Hamid Reza Aghaei Meybodi, Hoda Kavosi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Journal of Medical Case Reports |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13256-020-02416-7 |
Similar Items
-
Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis
by: Chuanjian Yuan, et al.
Published: (2023-06-01) -
Teriparatide - Indications beyond osteoporosis
by: Marilyn Lee Cheng, et al.
Published: (2012-01-01) -
Teriparatide as option for severe osteoporosis
by: Mara CARSOTE, et al.
Published: (2016-12-01) -
The cost effectiveness of teriparatide as a first-line treatment for glucocorticoid-induced and postmenopausal osteoporosis patients in Sweden
by: Murphy Daniel R, et al.
Published: (2012-10-01) -
Multiple Myeloma Case Developed During the Use of the Teriparatide
by: Zehra Erdemir, et al.
Published: (2022-04-01)